Alejandro F De Nicola Selected Research

Amyloid (Amyloid Fibrils)

10/2011	Experimental and clinical evidence for the protective role of progesterone in motoneuron degeneration and neuroinflammation.
12/2010	Protective effect of estrogens on the brain of rats with essential and endocrine hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alejandro F De Nicola Research Topics

Disease

16	Gliosis 08/2023 - 12/2002
15	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 12/2002
10	Multiple Sclerosis 04/2024 - 11/2007
9	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2024 - 04/2011
8	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2024 - 01/2008
7	Neuroinflammatory Diseases 08/2023 - 10/2011
7	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 01/2008
5	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023 - 12/2002
5	Inflammation (Inflammations) 01/2022 - 10/2007
4	Stroke (Strokes) 04/2024 - 12/2011
4	Hypertensive Encephalopathy 01/2023 - 04/2008
4	Neuralgia (Stump Neuralgia) 03/2016 - 01/2011
4	Hypertension (High Blood Pressure) 09/2013 - 01/2004
4	Ischemia 08/2012 - 12/2002
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2009 - 12/2002
3	Nervous System Diseases (Neurological Disorders) 01/2021 - 02/2007
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 10/2007
3	Atrophy 01/2020 - 02/2007
3	Ischemic Stroke 01/2017 - 10/2007
3	Chronic Pain 03/2016 - 01/2011
3	Pain (Aches) 03/2016 - 01/2011
2	Central Nervous System Diseases (CNS Diseases) 04/2024 - 07/2012
2	Brain Diseases (Brain Disorder) 07/2020 - 02/2015
2	Hypertrophy 01/2020 - 09/2014
2	Hyperalgesia 01/2016 - 01/2011
2	Motor Neuron Disease (Primary Lateral Sclerosis) 12/2013 - 12/2002
2	Wounds and Injuries (Trauma) 12/2010 - 11/2007
2	Brain Injuries (Brain Injury) 07/2009 - 07/2006
1	Sclerosis 01/2022
1	Fatigue 01/2020
1	Congenital Abnormalities (Deformity) 01/2020
1	Endometriosis 01/2019
1	Hyperplasia 01/2018
1	Myelitis 11/2015
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2015
1	Essential Hypertension 02/2015
1	Contusions 05/2014

Drug/Important Bio-Agent (IBA)

29	Progesterone FDA LinkGeneric 01/2022 - 12/2002
13	Messenger RNA (mRNA)IBA 01/2019 - 08/2002
12	SteroidsIBA 10/2023 - 07/2006
12	Proteins (Proteins, Gene)FDA Link 08/2023 - 02/2005
7	Estrogens (Estrogen)FDA Link 02/2015 - 08/2002
7	Estradiol (Delestrogen)FDA LinkGeneric 02/2015 - 07/2006
6	GlucocorticoidsIBA 08/2023 - 02/2009
6	Hormones (Hormone)IBA 07/2020 - 12/2002
6	NeurosteroidsIBA 11/2018 - 06/2004
6	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2015 - 02/2005
5	Neuroprotective AgentsIBA 01/2022 - 02/2007
5	EnzymesIBA 11/2018 - 02/2015
5	Streptozocin (Streptozotocin)FDA Link 02/2009 - 12/2002
4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 08/2023 - 02/2009
4	CorticosteroneIBA 08/2023 - 09/2014
3	ST 1435IBA 04/2024 - 11/2014
3	HMGB1 Protein (HMG1)IBA 08/2023 - 01/2018
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 11/2014
3	Progestins (Progestagens)IBA 01/2021 - 08/2013
3	SaltsIBA 12/2010 - 01/2004
2	CORT113176IBA 08/2023 - 01/2020
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2023 - 01/2018
2	Toll-Like Receptor 4IBA 01/2022 - 01/2018
2	Pregnanolone (Allopregnanolone)IBA 01/2022 - 08/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2018 - 01/2018
2	steroidogenic acute regulatory proteinIBA 11/2018 - 01/2016
2	CytokinesIBA 03/2016 - 07/2009
2	Amyloid (Amyloid Fibrils)IBA 10/2011 - 12/2010
2	Bromodeoxyuridine (BrdU)IBA 09/2011 - 12/2010
2	Myelin Basic ProteinIBA 01/2010 - 01/2008
2	Adenosine Triphosphatases (ATPase)IBA 07/2009 - 02/2005
2	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 07/2009 - 02/2007
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 07/2009 - 02/2009
2	Arginine Vasopressin (Argipressin)IBA 04/2008 - 01/2004
2	MineralocorticoidsIBA 04/2008 - 01/2004
2	NeuropeptidesIBA 03/2005 - 01/2004
1	Testosterone (Sustanon)FDA Link 04/2024
1	Eplerenone (Inspra)FDA LinkGeneric 01/2024
1	Mineralocorticoid Receptor AntagonistsIBA 01/2024
1	Purinergic Receptors (Receptors, Purine)IBA 08/2023
1	Phytoestrogens (Phytoestrogen)IBA 01/2023
1	NF-kappa B (NF-kB)IBA 01/2022
1	tiboloneIBA 01/2022
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022
1	InflammasomesIBA 01/2022
1	GTP-Binding Proteins (G-Protein)IBA 07/2020
1	Estrogen ReceptorsIBA 07/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	IsomerasesIBA 11/2018
1	CuprizoneIBA 11/2018
1	Oxidoreductases (Dehydrogenase)IBA 11/2018
1	Voltage-Dependent Anion ChannelsIBA 11/2018
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 03/2016
1	Aromatase (CYP19)IBA 02/2015
1	CORT 108297IBA 09/2014
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 12/2013
1	Therapeutic UsesIBA 12/2013
1	GABA-A Receptors (GABA(A) Receptor)IBA 08/2013

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2019
2	Contraception (Birth Control) 01/2019 - 08/2012
2	Injections 01/2016 - 01/2011
1	Immunomodulation 11/2015